WallStreetZenWallStreetZen

NASDAQ: UNCY
Unicycive Therapeutics Inc Stock

$1.38-0.08 (-5.48%)
Updated Mar 28, 2024
UNCY Price
$1.38
Fair Value Price
$0.22
Market Cap
$47.96M
52 Week Low
$0.47
52 Week High
$2.29
P/E
-1.08x
P/B
-12.59x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$30.54M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-4.73
Operating Cash Flow
-$18M
Beta
0.64
Next Earnings
Mar 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

UNCY Overview

Unicycive Therapeutics Inc., a biotechnology company, develops therapies for kidney diseases in the U.S. It is developing Renazorb, a treatment for hyperphosphatemia in patients with chronic kidney disease, and UNI 494, a treatment for Acute Kidney Injury. The company was incorporated in 2016 and is headquartered in Los Altos, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how UNCY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UNCY ($1.38) is overvalued by 521.59% relative to our estimate of its Fair Value price of $0.22 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
UNCY ($1.38) is not significantly undervalued (521.59%) relative to our estimate of its Fair Value price of $0.22 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
UNCY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more UNCY due diligence checks available for Premium users.

Be the first to know about important UNCY news, forecast changes, insider trades & much more!

UNCY News

Valuation

UNCY fair value

Fair Value of UNCY stock based on Discounted Cash Flow (DCF)
Price
$1.38
Fair Value
$0.22
Overvalued by
521.59%
UNCY ($1.38) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
UNCY ($1.38) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
UNCY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

UNCY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.08x
Industry
14.26x
Market
44.51x

UNCY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-12.59x
Industry
6.21x

UNCY's financial health

Profit margin

Revenue
$0.0
Net Income
-$7.8M
Profit Margin
0%
UNCY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$14.2M
Liabilities
$18.0M
Debt to equity
-4.73
UNCY's short-term liabilities ($17.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UNCY's short-term assets ($13.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UNCY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
UNCY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.4M
Investing
$0.0
Financing
-$205.0k
UNCY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

UNCY vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
UNCY$47.96M-5.48%-1.08x-12.59x
CASI$48.30M+20.33%-1.79x2.00x
DARE$48.30M-10.75%-1.04x-21.10x
DYAI$48.39M+2.45%-6.96x8.23x
APM$49.17M+9.08%-2.58x2.25x

Unicycive Therapeutics Stock FAQ

What is Unicycive Therapeutics's quote symbol?

(NASDAQ: UNCY) Unicycive Therapeutics trades on the NASDAQ under the ticker symbol UNCY. Unicycive Therapeutics stock quotes can also be displayed as NASDAQ: UNCY.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.

What is the 52 week high and low for Unicycive Therapeutics (NASDAQ: UNCY)?

(NASDAQ: UNCY) Unicycive Therapeutics's 52-week high was $2.29, and its 52-week low was $0.47. It is currently -39.66% from its 52-week high and 193.62% from its 52-week low.

How much is Unicycive Therapeutics stock worth today?

(NASDAQ: UNCY) Unicycive Therapeutics currently has 34,756,436 outstanding shares. With Unicycive Therapeutics stock trading at $1.38 per share, the total value of Unicycive Therapeutics stock (market capitalization) is $47.96M.

Unicycive Therapeutics stock was originally listed at a price of $5.85 in Jul 13, 2021. If you had invested in Unicycive Therapeutics stock at $5.85, your return over the last 2 years would have been -76.41%, for an annualized return of -51.43% (not including any dividends or dividend reinvestments).

How much is Unicycive Therapeutics's stock price per share?

(NASDAQ: UNCY) Unicycive Therapeutics stock price per share is $1.38 today (as of Mar 28, 2024).

What is Unicycive Therapeutics's Market Cap?

(NASDAQ: UNCY) Unicycive Therapeutics's market cap is $47.96M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Unicycive Therapeutics's market cap is calculated by multiplying UNCY's current stock price of $1.38 by UNCY's total outstanding shares of 34,756,436.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.